Synapse function in a mouse model of Alzheimer's disease
Synapse function in a mouse model of Alzheimer's disease
批准号:
7469504
负责人:
MATTHEW E FRERKING
金额:
$6.79万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-15 至 2009-05-31
关键词:
AddressAgeAge-MonthsAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid beta-Protein PrecursorApolipoprotein EAppearanceBehavioralBrain regionCessation of lifeChromosome PairingDefectDepositionEventExhibitsFiberGenesGlutamatesGoalsHippocampus (Brain)Impaired cognitionImpairmentLeadLearningLong-Term PotentiationMemoryMemory LossMethodsModelingMusMutationNeocortexNeurobehavioral ManifestationsNeurodegenerative DisordersNeurofibrillary TanglesNeurologicNeuronsPeptidesPhysiologicalPhysiological ProcessesPrevalenceProductionPropertyProteinsResearchResearch DesignSenile PlaquesSliceStudy modelsSynapsesSynaptic TransmissionSynaptic plasticityTechniquesThinkingTransgenic MiceTransgenic OrganismsVaccinatedWhole-Cell RecordingsWild Type Mouseabeta accumulationamyloid pathologybasefamilial Alzheimer diseaselong term memorymouse modelneurofibrillary tangle formationneuron losspatch clamppostsynapticpresenilinpresenilin-1presenilin-2receptorsynaptic functiontau Proteins
中文摘要
描述(由申请人提供):阿尔茨海默病(AD)是一种神经退行性疾病,可导致进行性认知障碍,最显著的是记忆丧失。AD的特征在于神经元损失和蛋白质沉积物(斑块)的积累以及许多脑区域(包括海马体,海马体是许多形式的学习和记忆的关键区域)中的神经元缠结。β-淀粉样蛋白肽(斑块的主要成分)的积聚被认为是与AD相关的认知障碍的因果因素,但对β-淀粉样蛋白积聚的生理效应(导致这些障碍)知之甚少。我们的长期目标是确定β-淀粉样蛋白损害认知的生理机制,以便开发治疗方法来保护这些机制,从而限制AD引起的损害。近年来,已经开发出几种AD的转基因小鼠模型。其中一个模型,即淀粉样前体蛋白(APR)和早老素-1(PS-1)均发生突变的小鼠系,其β-淀粉样蛋白水平显著快速增加,而不形成缠结或神经元丢失。APP/PS-1小鼠海马突触功能受损,早期长期突触可塑性缺陷,后期基础突触功能缺陷。然而,这些缺陷背后的机制仍然未知。在拟议的研究中,我们将确定APP/PS-1小鼠突触功能缺陷的潜在机制。将使用场电位记录和全细胞膜片钳记录在来自APP/PS-1小鼠和野生型同窝仔的海马切片中比较突触特性。将讨论两个具体目标。首先,我们将确定这些小鼠在长期可塑性的早期缺陷和基础突触传递的晚期缺陷中受损的突触机制。其次,我们将确定这些缺陷是否由β-淀粉样蛋白的积累引起。这项拟议中的研究将确定APP/PS-1突变导致海马突触功能受损的机制。项目相关性:拟议的研究将确定由β-淀粉样蛋白积累引起的突触缺陷的潜在机制,β-淀粉样蛋白被认为是AD认知障碍的主要因素。
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive cognitive impairments, most notably memory loss. AD is characterized by neuronal loss and by accumulation of protein deposits (plaques) and neurofibrillary tangles in many brain regions including the hippocampus, a region critical for many forms of learning and memory. The build-up of beta-amyloid peptides, a major component of plaques, is thought to be a causal factor in the cognitive impairments associated with AD, but the physiological effects of beta-amyloid accumulation that would cause these impairments are poorly understood. Our long-term objective is to define physiological mechanisms by which beta-amyloids impair cognition, so that therapies may be developed to protect these mechanisms and thereby limit the damage caused by AD. Recently, several transgenic mouse models for AD have been developed. One of these models, a mouse line with mutations in both amyloid precursor protein (APR) and presenilin-1 (PS-1), has a robust and rapid increase in the levels of beta-amyloids, without formation of tangles or neuronal loss. Hippocampal synaptic function in APP/PS-1 mice is impaired, with early defects in long-term synaptic plasticity and later defects in basal synaptic function. However, the mechanisms underlying these defects remain unknown. In the proposed research, we will identify mechanisms underlying the defects in synaptic function in APP/PS-1 mice. Synaptic properties will be compared in hippocampal slices from APP/PS-1 mice and wild- type littermates, using field potential recordings and whole-cell patch clamp recordings. Two specific aims will be addressed. First, we will identify the synaptic mechanisms that are impaired in these mice during early defects in long-term plasticity, and during late defects in basal synaptic transmission. Second, we will determine whether these defects are caused by the accumulation of beta-amyloids. The proposed research will identify the mechanisms by which APP/PS-1 mutations lead to impaired synaptic function in the hippocampus. Project relevance: The proposed research will identify mechanisms underlying synaptic defects caused by accumulation of beta-amyloids, which is thought to be a major factor in the cognitive impairments in AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Excitatory synaptic transmission onto hippocampal interneurons
-
批准号:8220870
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2010
-
负责人:MATTHEW E FRERKING
-
依托单位:
Excitatory synaptic transmission onto hippocampal interneurons
-
批准号:7779916
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2010
-
负责人:MATTHEW E FRERKING
-
依托单位:
Excitatory synaptic transmission onto hippocampal interneurons
-
批准号:8416448
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2010
-
负责人:MATTHEW E FRERKING
-
依托单位:
Excitatory synaptic transmission onto hippocampal interneurons
-
批准号:8020029
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2010
-
负责人:MATTHEW E FRERKING
-
依托单位:
Hippocampal synaptic dynamics during realistic patterns of afferent activity
-
批准号:7997239
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2007
-
负责人:MATTHEW E FRERKING
-
依托单位:
Synapse function in a mouse model of Alzheimer's disease
-
批准号:7208370
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2007
-
负责人:MATTHEW E FRERKING
-
依托单位:
Hippocampal synaptic dynamics during realistic patterns of afferent activity
-
批准号:8197539
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2007
-
负责人:MATTHEW E FRERKING
-
依托单位:
Hippocampal synaptic dynamics during realistic patterns of afferent activity
-
批准号:7541371
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2007
-
负责人:MATTHEW E FRERKING
-
依托单位:
Hippocampal synaptic dynamics during realistic patterns of afferent activity
-
批准号:7727930
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2007
-
负责人:MATTHEW E FRERKING
-
依托单位:
Kainate Receptors on Hippocampal Interneurons
-
批准号:7215193
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2003
-
负责人:MATTHEW E FRERKING
-
依托单位:
Kainate Receptors on Hippocampal Interneurons
-
批准号:6748177
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2003
-
负责人:MATTHEW E FRERKING
-
依托单位:
Kainate Receptors on Hippocampal Interneurons
-
批准号:6890965
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2003
-
负责人:MATTHEW E FRERKING
-
依托单位:
Kainate Receptors on Hippocampal Interneurons
-
批准号:7052059
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2003
-
负责人:MATTHEW E FRERKING
-
依托单位:
Kainate Receptors on Hippocampal Interneurons
-
批准号:6683551
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2003
-
负责人:MATTHEW E FRERKING
-
依托单位:
MECHANISMS UNDERLYING PLASTICITY OF RECEPTIVE FIELDS
-
批准号:6293966
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2000
-
负责人:MATTHEW E FRERKING
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: